NNutrition Read More Beware the ‘unholy trinity’ of supplementsAugust 28, 2026 That bottle in your medicine cabinet may deserve a closer look. Nearly three-quarters of American adults take dietary…
MMedication Read More Misbranding, storage lapses: FDA cancels Cipla Pune unit’s drug licence over Reactin Plus violations | Mumbai NewsAugust 28, 2026 The Maharashtra Food and Drug Administration has revoked Cipla’s licenses to sell Reactin Plus Tablets MUMBAI: The Maharashtra…
MMedication Read More FDA Announces Recall of Thyroid Medicine Due to Potential “Super Potency”August 28, 2026 If you take medication for an underactive thyroid, check your bottle right away. The U.S. Food and Drug…
HHealthcare Read More Revolution Medicines gets FDA nod for targeted pancreatic cancer drugAugust 26, 2026 Menta “Steve” Wallace shows a bottle of daraxonrasib, Revolution Medicines’ pancreatic cancer drug, at his home in The…
BBusiness Read More FDA Clears New Alzheimer’s Blood TestAugust 25, 2026 Topline The Food and Drug Administration has cleared a new blood test from Roche and Eli Lilly designed…
MMedication Read More Capricor (CAPR) Closed 58% Higher on an FDA Lifeline. Is Approval Really Back on Track?August 22, 2026 Capricor Therapeutics, Inc. (NASDAQ:CAPR) closed 58% higher at $6.65 on August 14 after the company said the FDA…
MMedication Read More Lawsuit claims link between GLP-1 weight loss drugs and blindness – Boston 25 NewsAugust 17, 2026 mASS. — A multi-district lawsuit involving more than 130 cases is before a Philadelphia judge, alleging that popular…
MMedication Read More Prescription Arthritis Medication Recalled Nationwide, FDA WarnsAugust 13, 2026 If you have rheumatoid arthritis and take an injection medication to treat your symptoms, you may want to…
HHealthcare Read More Medicare’s Drug-Pricing Proposal Carries A Hidden CostAugust 10, 2026 “CMS’s proposal would encourage one thing above all else: investing less in improving existing medicines,” says health expert…
MMedication Read More FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for ApprovalAugust 7, 2026 NRx Pharmaceuticals, Inc. FDA identified no major deficiencies related to the ketamine drug product, ingredients, proposed labeling, CMC,…
MMedication Read More FDA approves new OTC pain reliever that combines Tylenol and NaproxenAugust 6, 2026 (WXYZ) — If you’ve ever alternated between Tylenol and Aleve for pain relief, a new over-the-counter option may…
MMedication Read More RFK Jr.’s FDA Is Making Moves On Peptides — And Most Doctors Aren’t CelebratingAugust 6, 2026 It’s hard to go anywhere without hearing talk of peptides, currently paramount in people’s minds in large part…